SCImago Journal & Country Rank

Ranking and Indexing

Rank:
Index Copernicus Value (2010): 5.45
CNCSIS B+ (code 820) since 2007

International Databases:
SCOPUS since 2009
EBSCO Academic Search Complete since 2008
Index Copernicus Journals Master List since 2009
Directory of Open Access Journals (DOAJ) since 2008
ProQuest
Genamics JournalSeek since 18/2008

International Catalogues:
Oxford University's Library since 2003

Journal Info

Title: Studia Universitatis Vasile Goldis, Seria Stiintele Vietii (Life Sciences Series)
Abbreviated title: Studia Univ. VG, SSV
Publisher: "Vasile Goldis" University Press
Owner: Western University "Vasile Goldis" Arad, Romania
ISSN: 1584-2363
e-ISSN: 1842-7863
ISSN-L: 1584-2363

Who's Online

We have 88 guests online

Index Databases

Bioequivalence implies therapeutic equivalence. II. Economic and social approach Print E-mail
Written by Gherghiceanu F., Mircioiu C., Lupuleasa D., Mircioiu I., Iordache M., Toderescu C.D., Sandulovici R.   

Read full article
Article Title: Bioequivalence implies therapeutic equivalence. II.  Economic and social approach
Authors: Gherghiceanu F., Mircioiu C.,  Lupuleasa D., Mircioiu I., Iordache M., Toderescu C.D., Sandulovici R.
Affiliation: 1 ”Carol Davila” University of Medicine and Pharmacy, Faculty of Pharmacy, Dept of Biopharmacy Bucharest, Romania 3 2 “Titu Maiorescu “ University, Faculty of Pharmacy, Dept of Biopharmacy, Bucharest, Romania ”Carol Davila” University of Medicine and Pharmacy, Faculty of Pharmacy, Dept of Biophysics, Bucharest, Romania

Abstract: ABSTRACT: In spite of the fact that bioequivalent drugs are therapeutically equivalent, following a lot of apparent scientific disputes which traduce in fact the contradictions between different groups of interest, the sharing of the market between brand and generic drugs differs from country to country, which implies finally great differences in expenses and efficiency of health systems. Generic drugs account for 88% of all prescriptions filled USA and only 23 % in Romania. Authors consider that this situation decreases the availability for assurence of fundamental wright to health for poor people and propose two solutions for entering of Romania on the right. First is the modification of the curricula at universities of medicine and pharmacy by including biopharmacy and pharmacokinetics, GMP, GCP and QAS essential information. Second proposal is the renaissance of the public cotrol of drugs starting from the model of Institute for State Control and Research of Drugs based on the facilities and specialists of the faculties of pharmacy and National Institute for Chemico-Pharmaceutical Research and Development. Such an institution could convince medical doctors and patients that really Romanian generics drugs have the same quality as brand drugs.
Keywords: health politics,  generic drugs, bioequivalence, therapeutic equivalence,  public drug control
*Correspondence: Correspondence: Ion Mircioiu, “Titu Maiorescu“ University, Faculty of Pharmacy, Dept of Biopharmacy, Calea Vacaresti, 187, 040051, Bucharest, Romania, tel 0040722147004, e-mail: This e-mail address is being protected from spambots. You need JavaScript enabled to view it